US Tariffs on Pharma Firms Raise Concerns as Nifty Pharma Index Drops 4%

The Nifty Pharma index fell 4% for the fourth consecutive day due to reports that the Trump administration may impose new tariffs on drugmakers that haven't struck deals with the US government guaranteeing low prices. Biocon, Torrent Pharmaceuticals, and Sun Pharma were among the top losers, while Dr Reddy's was the only gainer.